Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,320 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

NCT00820846

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

NCT02852005

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

NCT00301184

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
View Trial Details
Completed

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants

NCT03928821

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Harlem Prevention Center CRS New York, United States
  • Columbia P&S CRS New York, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
View Trial Details
Completed

A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)

NCT03685500

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Hospital Puerta de Hierro Majadahonda, Madrid, Spain
  • Hospital Univ. 12 de Octubre Madrid, Spain
  • H. Univ. Príncipe de Asturias Madrid, Spain
  • Hospital Fundación Jimenez Diaz Madrid, Spain
View Trial Details

Related conditions